China Universal Asset Management Co., Ltd. Xenon Pharmaceuticals Inc. Transaction History
China Universal Asset Management Co., Ltd.
- $1.03 Billion
- Q4 2024
A detailed history of China Universal Asset Management Co., Ltd. transactions in Xenon Pharmaceuticals Inc. stock. As of the latest transaction made, China Universal Asset Management Co., Ltd. holds 16,166 shares of XENE stock, worth $645,831. This represents 0.06% of its overall portfolio holdings.
Number of Shares
16,166
Previous 14,572
10.94%
Holding current value
$645,831
Previous $573,000
10.47%
% of portfolio
0.06%
Previous 0.06%
Shares
15 transactions
Others Institutions Holding XENE
# of Institutions
212Shares Held
70.5MCall Options Held
88.3KPut Options Held
28.8K-
Avoro Capital Advisors LLC New York, NY5.67MShares$226 Million3.36% of portfolio
-
Driehaus Capital Management LLC Chicago, IL4.6MShares$184 Million1.77% of portfolio
-
Wellington Management Group LLP Boston, MA3.84MShares$154 Million0.03% of portfolio
-
Braidwell LP Stamford, CT2.71MShares$108 Million3.02% of portfolio
-
Commodore Capital LP New York, NY2.7MShares$108 Million9.03% of portfolio
About Xenon Pharmaceuticals Inc.
- Ticker XENE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,263,500
- Market Cap $2.49B
- Description
- Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN496, A Kv7 potassium channel opener that is Phase III clinical trials for the treatment of KCNQ2 developmental and epilepsy encephalopath...